Towards Healthcare
U.S. Home Infusion Therapy Market to Advance $36.88 Bn by 2034

U.S. Home Infusion Therapy Market Advancing Patient Care and Outcomes

The U.S. home infusion therapy industry is projected to rise from USD 18.23 billion in 2024 to USD 36.88 billion by 2034, reflecting a CAGR of 7.3% over the next decade. Home infusion therapy in the U.S. lets patients receive medications like antibiotics, pain management, or nutrition through an IV at home instead of a hospital. It’s a convenient, cost-effective option for chronic conditions, reducing hospital stays while ensuring safe, professional care from nurses or pharmacists.

Content

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global U.S. Home Infusion Therapy Market Assessment

  • Overview
  • Global U.S. Home Infusion Therapy Market Size Value (US$) and Volume (Billion Tons), by Product (2021 – 2033)
    • Infusion Pump
      • Elastomeric
      • Electrochemical
      • Gravity
      • Others
    • Intravenous Sets
    • IV Cannulas
    • Needless Connectors
    • Others
  • Global U.S. Home Infusion Therapy Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
    • Anti-Infective Therapy
    • Enteral Nutrition
    • Parenteral Nutrition
    • Chemotherapy
    • Hydration Therapy
    • Chronic Diseases
    • Speciality Pharmaceuticals

Company Profiles

  • Option Care Health, Inc.
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • B. Braun Medical, Inc.
  • Baxter International Inc.
  • Fresenius Kabi USA
  • Amedisys, Inc.
  • CareCentrix, Inc.
  • ICU Medical
  • Smiths Medical, Inc.
  • CareFusion
  • Caesarea Medical Electronics Ltd.

Conclusion & Recommendations

  • Insight Code: 5102
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: April 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

Home infusion therapy involves administering medications or fluids through a needle or catheter at home instead of in a hospital or clinic setting.

Infusion therapy involves delivering medications for infections, pain management or chronic diseases directly into the bloodstream. It also includes hydration for patients unable to consume enough liquids orally and nutrition support through intravenous administration of nutrients and vitamins. The blood transfusions for conditions like anemia and chemotherapy by administering cancer-fighting drugs directly into the bloodstream, effectively managing various medical conditions.

The increase in chronic disorders is one of the major reasons for the growth of the U.S. home infusion therapy market. The rise in chronic conditions requiring long-term treatment, such as cancer, diabetes and autoimmune diseases, fuels the demand for infusion therapies.

World Health Organization, National Home Infusion Foundation, Center for Disease Control and Prevention, American Cancer Society, ScienceDirect Publication.
Any Questions